
| Pair Name | Thymoquinone, Methotrexate | ||
| Phytochemical Name | Thymoquinone (PubChem CID: 10281 ) | ||
| Anticancer drug Name | Methotrexate (PubChem CID: 126941 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Thymoquinone, Methotrexate | |||
| Disease Info | [ICD-11: 2B51] | Osteosarcoma | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
| Up-regulation | Expression | CASP3 | hsa836 | |
| Down-regulation | Expression | BCL2 | hsa596 | |
| In Vitro Model | SaOS-2 | Osteosarcoma | Homo sapiens (Human) | CVCL_0548 |
| Result | The findings of the present study highlight new insights into understanding the role of TQ as a potential therapeutic agent in osteosarcoma by increasing MTX-induced apoptosis. | |||
| Pair Name | Thymoquinone, Methotrexate | |||
| Disease Info | [ICD-11: 2B51] | Osteosarcoma | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
| Up-regulation | Expression | CASP9 | hsa842 | |
| Down-regulation | Expression | BCL2 | hsa596 | |
| In Vitro Model | SaOS-2 | Osteosarcoma | Homo sapiens (Human) | CVCL_0548 |
| Result | The co-treatment of TQ and MTX is associated with the up-regulation of apoptotic factors and down-regulation of anti-apoptotic factors, conducting apoptosis aggravation and OS cell death. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Thymoquinone Potentiates Methotrexate Mediated-Apoptosis in Saos-2 Osteosarcoma Cell Line. Drug Res (Stuttg). 2022 Sep;72(7):390-395. doi: 10.1055/a-1842-7545. | Click |
| 2 | Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells. Drug Res (Stuttg). 2022 Apr;72(4):220-225. doi: 10.1055/a-1775-7908. | Click |